Yayınlar & Eserler

Yayın Ağı
Makaleler 5
Tümü (5)
SCI-E, SSCI, AHCI (4)
SCI-E, SSCI, AHCI, ESCI (4)
Scopus (4)
TRDizin (1)

1. HSR26-226: Adult Langerhans Cell Histiocytosis: A Ten-Year Single-Center Experience from Çukurova University Hematology Unit

Turunç A., Dinçyürek H. D., Çubukçu Y. B., GÜVENÇ B.
Journal of the National Comprehensive Cancer Network : JNCCN , cilt.24, sa.35, 2026 (SCI-Expanded, Scopus)

2. Seven-Year Course of Hypoplastic Myelodysplastic Syndrome Unmasked by Secondary and Neurological Syphilis

Turunç A., Dinçyürek H. D., GÜVENÇ B.
Mediterranean Journal of Hematology and Infectious Diseases , cilt.18, sa.1, 2026 (SCI-Expanded, Scopus) Creative Commons License

3. EZH-2 expression and prognostic significance in patients with low-grade non-Hodgkin lymphoma

ŞENER M., Dinçyürek H. D., TOTİK N., Bağır E. K., PAYDAŞ S., GÜRKAN E.
Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)

4. Immune and Inflammation Markers as a Predictor of Overall Survival in Patients with Hematologic Malignancies: A Retrospective Cohort Study

Ucar M. A., Tombak A., Akdeniz A., DİNÇYÜREK H. D., ŞENER M., Koyuncu M. B., et al.
Medicina (Lithuania) , cilt.61, sa.6, 2025 (SCI-Expanded, Scopus)

5. Oküler Graft Versus Host Hastalığında Prognozu Etkileyen Faktörler

Gul Olke K., ERDEM E., HARBİYELİ İ. İ., Dinçyürek H. D., GÜVENÇ B., KARAGÜN B., et al.
MN Oftalmoloji , cilt.30, sa.2, ss.112-118, 2023 (TRDizin)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 8

1. İNDOLENT NON-HODGKİN LENFOMA HASTALARINDA EZH-2 İFADESİNİN PROGNOZ ÜZERİNDE ETKİSİ

ŞENER M., KILIÇ BAĞIR E., DİNÇYÜREK H. D., SEYDAOĞLU G., PAYDAŞ S., GÜRKAN E.
46. Ulusal Hematoloji Kongresi/sanal kongre, Türkiye, 28 - 31 Ekim 2020, ss.90-91, (Tam Metin Bildiri)

2. TREATMENT OF REFRACTORY LANGERHANS CELL HISTIOCYTOSIS WITH CLADRIBINE: CASE REPORT

Kis C., DİNÇYÜREK H. D., Mutlu Y. G., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

3. HODGKIN LYMPHOMA TRANSFORMATION OF CHRONIC LYMPHOCYTIC LEUKEMIA: A CASE REPORT

DİNÇYÜREK H. D., MUTLU Y. G., KIS C., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

4. PROTHROMBIN COMPLEX CONCENTRATE (PCC) PROPHYLAXIS IN PATIENT WITH HEREDITARY COMBINED VITAMIN K-DEPENDENT CLOTTING FACTORS DEFICIENCY (VKCFD): CASE REPORT

Kis C., DİNÇYÜREK H. D., Mutlu Y. G., Cor S., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

5. BORTEZOMIB THERAPY IN A REFRACTORY IMMUN HEMOLYTIC ANEMIA AS A STEROID SPARING AGENT

DİNÇYÜREK H. D., Mutlu Y. G., Kis C., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

6. SUCCESSFUL PREGNANCY AND DELIVERY IN AFIBRINOGENEMIA PATIENT: CASE REPORT

DİNÇYÜREK H. D., Mutlu Y. G., Cor S., Gok G., Evruke C., Demir C., et al.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

7. BORTEZOMIB AND RITUXIMAB COMBINATION AS A SALVAGE THERAPY IN A PATIENT WITH REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA: CASE REPORT

Mutlu Y. G., DİNÇYÜREK H. D., Kis C., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

8. EFFECTIVE RITUXIMAB THERAPY OF PLASMA EXCHANGE AND STREOID RESISTANT SEVERE AUTOIMMUNE HEMOLYTIC ANEMIA DUE TO ANTIPHOSPHOLIPID SYNDROME: CASE REPORT

KIS C., DİNÇYÜREK H. D., MUTLU Y. G., GÜVENÇ B.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
Metrikler

Yayın

13

Yayın (WoS)

11

Yayın (Scopus)

4

Atıf (Scopus)

11

H-İndeks (Scopus)

1

Açık Erişim

1